These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 31913695)

  • 21. Emerging importance of chemokine receptor CXCR3 and its ligands in cardiovascular diseases.
    Altara R; Manca M; Brandão RD; Zeidan A; Booz GW; Zouein FA
    Clin Sci (Lond); 2016 Apr; 130(7):463-78. PubMed ID: 26888559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targeting.
    Lee HJ; Song IC; Yun HJ; Jo DY; Kim S
    World J Gastroenterol; 2014 Feb; 20(7):1681-93. PubMed ID: 24587647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CXCR3/CXCR3 ligand biological axis impairs RENCA tumor growth by a mechanism of immunoangiostasis.
    Pan J; Burdick MD; Belperio JA; Xue YY; Gerard C; Sharma S; Dubinett SM; Strieter RM
    J Immunol; 2006 Feb; 176(3):1456-64. PubMed ID: 16424173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CXCR3-binding chemokines: novel multifunctional therapeutic targets.
    Lazzeri E; Romagnani P
    Curr Drug Targets Immune Endocr Metabol Disord; 2005 Mar; 5(1):109-18. PubMed ID: 15777209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes.
    Kawada K; Sonoshita M; Sakashita H; Takabayashi A; Yamaoka Y; Manabe T; Inaba K; Minato N; Oshima M; Taketo MM
    Cancer Res; 2004 Jun; 64(11):4010-7. PubMed ID: 15173015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemokine-mediated tissue recruitment of CXCR3+ CD4+ T cells plays a major role in the pathogenesis of chronic GVHD.
    Croudace JE; Inman CF; Abbotts BE; Nagra S; Nunnick J; Mahendra P; Craddock C; Malladi R; Moss PA
    Blood; 2012 Nov; 120(20):4246-55. PubMed ID: 23012327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome.
    Belperio JA; Keane MP; Burdick MD; Lynch JP; Xue YY; Li K; Ross DJ; Strieter RM
    J Immunol; 2002 Jul; 169(2):1037-49. PubMed ID: 12097412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis.
    Hensbergen PJ; Wijnands PG; Schreurs MW; Scheper RJ; Willemze R; Tensen CP
    J Immunother; 2005; 28(4):343-51. PubMed ID: 16000952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of CXC group chemokines in lung cancer development and progression.
    Spaks A
    J Thorac Dis; 2017 Apr; 9(Suppl 3):S164-S171. PubMed ID: 28446981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells.
    Zipin-Roitman A; Meshel T; Sagi-Assif O; Shalmon B; Avivi C; Pfeffer RM; Witz IP; Ben-Baruch A
    Cancer Res; 2007 Apr; 67(7):3396-405. PubMed ID: 17409450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CXCR3 ligands in disease and therapy.
    Van Raemdonck K; Van den Steen PE; Liekens S; Van Damme J; Struyf S
    Cytokine Growth Factor Rev; 2015 Jun; 26(3):311-27. PubMed ID: 25498524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production.
    Romagnani P; Maggi L; Mazzinghi B; Cosmi L; Lasagni L; Liotta F; Lazzeri E; Angeli R; Rotondi M; Filì L; Parronchi P; Serio M; Maggi E; Romagnani S; Annunziato F
    J Allergy Clin Immunol; 2005 Dec; 116(6):1372-9. PubMed ID: 16337473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis.
    Addison CL; Arenberg DA; Morris SB; Xue YY; Burdick MD; Mulligan MS; Iannettoni MD; Strieter RM
    Hum Gene Ther; 2000 Jan; 11(2):247-61. PubMed ID: 10680839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of IFN-gamma induced CXCR3 agonist chemokines and compartmentalization of CXCR3+ cells in the periphery and lymph nodes of rhesus macaques during simian immunodeficiency virus infection and acquired immunodeficiency syndrome.
    Sarkar S; Kalia V; Murphey-Corb M; Montelaro RC; Reinhart TA
    J Med Primatol; 2003 Aug; 32(4-5):247-64. PubMed ID: 14498985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemokine profiling in serum from patients with ovarian cancer reveals candidate biomarkers for recurrence and immune infiltration.
    Mlynska A; Salciuniene G; Zilionyte K; Garberyte S; Strioga M; Intaite B; Barakauskiene A; Lazzari G; Dobrovolskiene N; Krasko JA; Pasukoniene V
    Oncol Rep; 2019 Feb; 41(2):1238-1252. PubMed ID: 30483809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
    Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
    Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CXCL4-induced migration of activated T lymphocytes is mediated by the chemokine receptor CXCR3.
    Mueller A; Meiser A; McDonagh EM; Fox JM; Petit SJ; Xanthou G; Williams TJ; Pease JE
    J Leukoc Biol; 2008 Apr; 83(4):875-82. PubMed ID: 18174362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia.
    Jones D; Benjamin RJ; Shahsafaei A; Dorfman DM
    Blood; 2000 Jan; 95(2):627-32. PubMed ID: 10627472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Chemokine Receptor CXCR3 and Its Ligands in Renal Cell Carcinoma.
    Gudowska-Sawczuk M; Kudelski J; Mroczko B
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SLC/exodus2/6Ckine/TCA4 induces chemotaxis of hematopoietic progenitor cells: differential activity of ligands of CCR7, CXCR3, or CXCR4 in chemotaxis vs. suppression of progenitor proliferation.
    Kim CH; Broxmeyer HE
    J Leukoc Biol; 1999 Sep; 66(3):455-61. PubMed ID: 10496316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.